UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.   )


Filed by the Registrant ☒
Filed by a party other than the Registrant  ☐

Check the appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐
Definitive Proxy Statement
☒
Definitive Additional Materials
☐
Soliciting Material Pursuant to Sec.240.14a-12

Infinity Pharmaceuticals, Inc.
(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):
☒
No fee required.
☐
Fee paid previously with preliminary materials.
☐
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

Infinity Pharmaceuticals (NASDAQ:INFI)
過去 株価チャート
から 5 2024 まで 6 2024 Infinity Pharmaceuticalsのチャートをもっと見るにはこちらをクリック
Infinity Pharmaceuticals (NASDAQ:INFI)
過去 株価チャート
から 6 2023 まで 6 2024 Infinity Pharmaceuticalsのチャートをもっと見るにはこちらをクリック